MedPath
HSA Approval

LISINOPRIL STADA TABLET 20 mg

SIN11597P

LISINOPRIL STADA TABLET 20 mg

LISINOPRIL STADA TABLET 20 mg

July 26, 2001

DCH AURIGA SINGAPORE

DCH AURIGA SINGAPORE

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantDCH AURIGA SINGAPORE
Licence HolderDCH AURIGA SINGAPORE

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

C09AA03

lisinopril

Manufacturer Information

DCH AURIGA SINGAPORE

Stellapharm J.V. Co., Ltd. - Branch 1

Active Ingredients

LISINOPRIL DIHYDRATE EQV LISINOPRIL (ANHYDROUS)

20 mg

Lisinopril

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.